STERIS (STE) reported fiscal 2027 first-quarter revenue of $1.5 billion, up 7% from $1.4 billion a year earlier. As reported net income was $200.1 million, or $2.04 per diluted share, compared with $177.4 million, or $1.79 per diluted share, in the prior-year quarter.
The company reiterated fiscal 2027 guidance for reported revenue growth of 7% to 8% and adjusted diluted EPS of $11.10 to $11.30. STERIS also announced a targeted restructuring plan tied to a new formulated chemistries Center of Excellence in North Carolina.
- Total revenue was $1.4927 billion for the quarter ended June 30, 2026.
- Healthcare revenue rose 8% to $1.05 billion, AST revenue increased 6% to $297.6 million, and Life Sciences revenue increased 9% to $146.7 million.
- Net cash provided by operations was $367.1 million, compared with $420.0 million a year earlier.
- The restructuring plan is expected to result in pre-tax charges of about $55 million to $70 million over time.
- Capital expenditures guidance increased to about $450 million, while free cash flow guidance was revised to about $800 million.
$STE Insider Trading Activity
$STE insiders have traded $STE stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $STE stock by insiders over the last 6 months:
- DANIEL A CARESTIO (President and CEO) has made 0 purchases and 2 sales selling 4,428 shares for an estimated $946,798.
- CYNTHIA L FELDMANN sold 3,098 shares for an estimated $734,876
- RICHARD C BREEDEN sold 1,481 shares for an estimated $310,284
- JOHN ADAM ZANGERLE (Sr. VP, Gen Counsel, and Sec.) sold 1,419 shares for an estimated $296,968
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$STE Hedge Fund Activity
We have seen 312 institutional investors add shares of $STE stock to their portfolio, and 476 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,417,618 shares (+410.3%) to their portfolio in Q1 2026, for an estimated $313,477,868
- WELLINGTON MANAGEMENT GROUP LLP added 1,229,286 shares (+74.8%) to their portfolio in Q1 2026, for an estimated $271,832,013
- APG ASSET MANAGEMENT N.V. removed 936,615 shares (-92.3%) from their portfolio in Q1 2026, for an estimated $207,113,674
- ALLIANCEBERNSTEIN L.P. removed 844,064 shares (-63.1%) from their portfolio in Q1 2026, for an estimated $186,647,872
- MITSUBISHI UFJ ASSET MANAGEMENT CO., LTD. added 651,271 shares (+42.2%) to their portfolio in Q1 2026, for an estimated $144,015,556
- BOSTON PARTNERS added 636,081 shares (+73.8%) to their portfolio in Q2 2026, for an estimated $133,939,576
- PICTET ASSET MANAGEMENT HOLDING SA removed 582,183 shares (-70.7%) from their portfolio in Q2 2026, for an estimated $122,590,274
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$STE Congressional Stock Trading
Members of Congress have traded $STE stock 12 times in the past 6 months. Of those trades, 8 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $STE stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 7 times. They made 3 purchases worth up to $45,000 on 04/30, 03/16, 02/06 and 4 sales worth up to $60,000 on 07/31, 07/29, 07/27, 07/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 5 purchases worth up to $75,000 on 05/13, 05/11, 05/01, 04/29, 02/10 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
